- Home
- Publications
- Publication Search
- Publication Details
Title
Apheresis: What Should a Clinician Know?
Authors
Keywords
-
Journal
Current Atherosclerosis Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-01-26
DOI
10.1007/s11883-023-01081-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Lipoprotein Apheresis on Progression of Carotid Intima-Media Thickness in Patients with Severe Hypercholesterolemia
- (2022) Maya S. Safarova et al. AMERICAN JOURNAL OF CARDIOLOGY
- Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
- (2021) Henry N Ginsberg et al. EUROPEAN HEART JOURNAL
- Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a)
- (2019) Elisa Waldmann et al. PATHOLOGY
- Current Role of Lipoprotein Apheresis
- (2019) Gilbert Thompson et al. Current Atherosclerosis Reports
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Lipoprotein Apheresis for Lipoprotein(a) and Cardiovascular Disease
- (2019) Patrick M. Moriarty et al. Journal of Clinical Lipidology
- Reduced incidence of cardiovascular events in hyper-Lp(a) patients on lipoprotein apheresis. The G.I.L.A. (Gruppo Interdisciplinare Aferesi Lipoproteica) pilot study
- (2018) Federico Bigazzi et al. TRANSFUSION AND APHERESIS SCIENCE
- From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients
- (2018) Maria G Zenti et al. European Journal of Preventive Cardiology
- Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial
- (2017) Tina Z. Khan et al. EUROPEAN HEART JOURNAL
- Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial
- (2016) Patrick M. Moriarty et al. EUROPEAN HEART JOURNAL
- Lipoprotein apheresis to treat elevated lipoprotein (a)
- (2016) Elisa Waldmann et al. JOURNAL OF LIPID RESEARCH
- Does Regular Lipid Apheresis in Patients With Isolated Elevated Lipoprotein(a) Levels Reduce the Incidence of Cardiovascular Events?
- (2013) Adrian Rosada et al. ARTIFICIAL ORGANS
- Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography
- (2013) Maya S. Safarova et al. ATHEROSCLEROSIS SUPPLEMENTS
- Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease
- (2013) Josef Leebmann et al. CIRCULATION
- Lipid apheresis, indications, and principles
- (2011) Jeffrey L. Winters JOURNAL OF CLINICAL APHERESIS
- Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
- (2011) Anne C. Goldberg et al. Journal of Clinical Lipidology
- Immunosorbent for Selective Removal of Lipoprotein (a) from Human Plasma: In Vitro Study
- (2010) Sergei N. Pokrovsky et al. ARTIFICIAL ORGANS
- Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe
- (2010) Gilbert R Thompson et al. CURRENT OPINION IN LIPIDOLOGY
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
- (2009) Pia R. Kamstrup JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Recommendations for the use of LDL apheresis
- (2008) G.R. Thompson ATHEROSCLEROSIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started